Oncology Institute Stock Market Value
| TOI Stock | USD 0.15 0 2.67% |
| Symbol | Oncology |
Oncology Institute Price To Book Ratio
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Oncology Institute. If investors know Oncology will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Oncology Institute listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.77) | Revenue Per Share 4.873 | Quarterly Revenue Growth 0.229 | Return On Assets (0.19) | Return On Equity (1.26) |
The market value of Oncology Institute is measured differently than its book value, which is the value of Oncology that is recorded on the company's balance sheet. Investors also form their own opinion of Oncology Institute's value that differs from its market value or its book value, called intrinsic value, which is Oncology Institute's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Oncology Institute's market value can be influenced by many factors that don't directly affect Oncology Institute's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Oncology Institute's value and its price as these two are different measures arrived at by different means. Investors typically determine if Oncology Institute is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Oncology Institute's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Oncology Institute 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Oncology Institute's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Oncology Institute.
| 09/30/2023 |
| 11/23/2024 |
If you would invest 0.00 in Oncology Institute on September 30, 2023 and sell it all today you would earn a total of 0.00 from holding Oncology Institute or generate 0.0% return on investment in Oncology Institute over 420 days. Oncology Institute is related to or competes with Ramsay Health, Medical Facilities, Fresenius, Lifestance Health, Agilon Health, Pennant, and Brookdale Senior. The Oncology Institute, Inc., an oncology company, provides medical oncology services in the United States More
Oncology Institute Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Oncology Institute's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Oncology Institute upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.14) | |||
| Maximum Drawdown | 39.32 | |||
| Value At Risk | (10.34) | |||
| Potential Upside | 8.82 |
Oncology Institute Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Oncology Institute's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Oncology Institute's standard deviation. In reality, there are many statistical measures that can use Oncology Institute historical prices to predict the future Oncology Institute's volatility.| Risk Adjusted Performance | (0.09) | |||
| Jensen Alpha | (1.15) | |||
| Total Risk Alpha | (1.85) | |||
| Treynor Ratio | (0.40) |
Oncology Institute Backtested Returns
Oncology Institute maintains Sharpe Ratio (i.e., Efficiency) of -0.15, which implies the firm had a -0.15% return per unit of risk over the last 3 months. Oncology Institute exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Oncology Institute's Variance of 51.04, risk adjusted performance of (0.09), and Coefficient Of Variation of (783.81) to confirm the risk estimate we provide. The company holds a Beta of 2.32, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Oncology Institute will likely underperform. At this point, Oncology Institute has a negative expected return of -1.08%. Please make sure to check Oncology Institute's treynor ratio, as well as the relationship between the daily balance of power and period momentum indicator , to decide if Oncology Institute performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.05 |
Very weak reverse predictability
Oncology Institute has very weak reverse predictability. Overlapping area represents the amount of predictability between Oncology Institute time series from 30th of September 2023 to 27th of April 2024 and 27th of April 2024 to 23rd of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Oncology Institute price movement. The serial correlation of -0.05 indicates that only as little as 5.0% of current Oncology Institute price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.05 | |
| Spearman Rank Test | 0.21 | |
| Residual Average | 0.0 | |
| Price Variance | 0.04 |
Oncology Institute lagged returns against current returns
Autocorrelation, which is Oncology Institute stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Oncology Institute's stock expected returns. We can calculate the autocorrelation of Oncology Institute returns to help us make a trade decision. For example, suppose you find that Oncology Institute has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Oncology Institute regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Oncology Institute stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Oncology Institute stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Oncology Institute stock over time.
Current vs Lagged Prices |
| Timeline |
Oncology Institute Lagged Returns
When evaluating Oncology Institute's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Oncology Institute stock have on its future price. Oncology Institute autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Oncology Institute autocorrelation shows the relationship between Oncology Institute stock current value and its past values and can show if there is a momentum factor associated with investing in Oncology Institute.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
When determining whether Oncology Institute offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Oncology Institute's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Oncology Institute Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Oncology Institute Stock:Check out Oncology Institute Correlation, Oncology Institute Volatility and Oncology Institute Alpha and Beta module to complement your research on Oncology Institute. For more detail on how to invest in Oncology Stock please use our How to Invest in Oncology Institute guide.You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Oncology Institute technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.